Arvinas Inc (ARVN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ARVN | AMGN | VRTX | REGN | GSK |
| Company | Arvinas Inc | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gsk Plc ADR |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 33.41 | 306.79 | 455.00 | 980.16 | 41.22 |
| High | 33.76 | 311.48 | 471.39 | 1,001.04 | 41.72 |
| Low | 27.80 | 303.85 | 453.73 | 979.26 | 40.51 |
| Last | 27.89 | 307.42 | 470.18 | 989.48 | 40.88 |
| Change | -5.25 | +1.57 | +14.84 | +9.32 | -3.89 |
| % Change | -15.84% | +0.51% | +3.26% | +0.95% | -8.69% |
| Volume | 1,716,000 | 2,447,300 | 1,971,000 | 532,900 | 13,482,785 |
| 20-Day Average Volume | 760,030 | 2,592,555 | 1,259,915 | 388,930 | 3,955,310 |
| Previous Close | 33.14 | 305.85 | 455.34 | 980.16 | 44.77 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 32.96 | 307.91 | 437.75 | 976.30 | 44.56 |
| 20-Day Raw Stochastic | 0.94% | 45.97% | 98.44% | 77.23% | 6.83% |
| 20-Day Relative Strength | 33.24% | 57.51% | 71.85% | 59.71% | 38.64% |
| Weighted Alpha | -31.04 | +36.15 | +44.02 | +32.24 | +15.58 |
| Today's Opinion | 56% Sell | 72% Buy | 88% Buy | 88% Buy | 48% Buy |
| Previous Opinion | 32% Sell | 72% Buy | 88% Buy | 88% Buy | 100% Buy |
| Last Month's Opinion | 24% Sell | 16% Sell | 8% Buy | 48% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -20.83% since 05/24/24 | +0.52% since 05/24/24 | +2.90% since 05/24/24 | +0.45% since 05/24/24 | -9.40% since 05/24/24 |
| Low | 27.80 on 06/03/24 | 295.49 on 05/30/24 | 435.57 on 05/30/24 | 952.30 on 05/30/24 | 40.51 on 06/03/24 |
| High | 36.20 on 05/28/24 | 311.48 on 06/03/24 | 471.39 on 06/03/24 | 1,001.04 on 06/03/24 | 45.01 on 05/31/24 |
| 1-Month | |||||
| %Chg | -15.02% since 05/03/24 | -1.24% since 05/03/24 | +17.23% since 05/03/24 | +3.39% since 05/03/24 | -6.02% since 05/03/24 |
| Low | 27.80 on 06/03/24 | 295.49 on 05/30/24 | 394.03 on 05/07/24 | 950.27 on 05/06/24 | 40.51 on 06/03/24 |
| High | 37.38 on 05/22/24 | 321.44 on 05/15/24 | 471.39 on 06/03/24 | 1,001.04 on 06/03/24 | 45.92 on 05/15/24 |
| 3-Month | |||||
| %Chg | -41.04% since 03/01/24 | +9.66% since 03/01/24 | +8.65% since 03/01/24 | +0.68% since 03/01/24 | -2.74% since 03/01/24 |
| Low | 27.80 on 06/03/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 39.15 on 04/18/24 |
| High | 49.76 on 03/08/24 | 322.60 on 05/03/24 | 471.39 on 06/03/24 | 1,001.04 on 06/03/24 | 45.92 on 05/15/24 |
| 6-Month | |||||
| %Chg | +18.18% since 12/01/23 | +12.84% since 12/01/23 | +33.89% since 12/01/23 | +21.43% since 12/01/23 | +11.79% since 12/01/23 |
| Low | 22.34 on 12/05/23 | 260.68 on 04/19/24 | 347.51 on 12/04/23 | 802.55 on 12/04/23 | 35.81 on 12/07/23 |
| High | 53.08 on 02/16/24 | 329.72 on 02/05/24 | 471.39 on 06/03/24 | 1,001.04 on 06/03/24 | 45.92 on 05/15/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,267,836 | 164,068,656 | 117,501,856 | 107,999,904 | 92,783,136 |
| Shares Outstanding, K | 68,432 | 536,435 | 258,053 | 110,186 | 2,072,440 |
| Annual Sales | 78,500,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 37,725,000,000 |
| Annual Net Income | -367,300,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 6,129,940,000 |
| Last Quarter Sales | 25,300,000 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 9,337,020,000 |
| Last Quarter Net Income | -69,400,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | 1,326,430,000 |
| 60-Month Beta | 1.95 | 0.60 | 0.39 | 0.17 | 0.65 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.97 on 05/07/24 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | 1.09 on 05/01/24 |
| Latest Earnings Date | 05/10/24 | 05/02/24 | 05/06/24 | 05/02/24 | 07/24/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.369 on 05/16/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 05/16/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.16 | 29.42 | 26.14 | 10.90 |